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Purpose: Discs large (dlg), scribble (scrib), and lethal giant larvae (lgl) are major suppressor genes in Drosophila
melanogaster. They encode proteins that regulate cell polarity and cell proliferation in  Drosophila and mammals.
However, their basic oncogenic roles have not yet been established in mouse epithelial ocular cancer. We evaluated the
potential implication of these proteins in tumorigenesis of adenocarcinomas originating from the retinal pigmented
epithelium of the Trp1/Tag transgenic mouse model. We examined the changes in the distribution and levels of these
proteins in mouse ocular tissues from the Trp1/Tag mouse model.
Methods: The expression patterns of theses genes and their corresponding proteins in normal mouse ocular tissues were
studied by in situ hibridization and immunohistofluorescence experiments. In addition, variations in mRNA and proteins
levels and protein distributions for Dlg1, Scrib, and Lgl1 were analyzed in the ocular tissues from Trp1/Tag transgenic
mouse  model  by  reverse  transcription  polymerase  chain  reaction  (RT–PCR),  western  blot  analysis,  and
immunohistofluorescence.
Results: We found that mouse Dlg1, Scrib, and Lgl1 are widely distributed in normal ocular tissues, particularly in retinal
neurons.  We  found  that  the  three  proteins  are  mislocalized  in  retinal  layers  during  ocular  carcinogenesis.  These
mislocalizations were correlated to the early dysplastic stages of ocular tumorigenesis. Additionally, the mislocalization
of each protein was associated with its downregulation. Decreased levels of these proteins may be considered as late-stage
markers of the disease but also as markers of the invasive stage of this cancerous process. This downregulation may be
involved in epithelial-mesenchymal transition in this mouse ocular tumoral model. This would be consistent with the
downregulation of E-cadherin and upregulation of N-cadherin expression observed in this model.
Conclusions: This is the first study to demonstrate the involvement of Dlg1, Scrib, and Lgl1 in a mouse with ocular
adenocarcinoma and the simultaneous involvement of these proteins in the same cancer. Our results indicate that both the
mislocalization and downregulation of these proteins may be involved together in ocular carcinogenesis.
Epithelial cells display an apico-basal polarity that is
required for their correct epithelial structure and function [1].
Moreover, loss of epithelial polarity and architecture is one of
the hallmarks of aggressive and invasive cancers. Polarity is
mediated  by  the  presence  of  different  cell  junctions  and
dependent on the formation of multiprotein complexes at the
cell membrane. Most of our understanding about the link
between cell polarity and the control of proliferation comes
from studies on the Drosophila melanogaster genes, discs
large (dlg), scribble (scrib), and lethal giant larvae (lgl), and
their protein products [2,3]. Mutation analysis of these three
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genes  in  Drosophila  melanogaster  has  revealed  a  link
between the regulation of cell polarity and the control of cell
proliferation. Indeed, mutations in any one of these genes
cause loss of apico-basal cell polarity, loss of the columnar
monolayered organization, and hyperproliferation, forming
large neoplastic cell masses in the larval brain and imaginal
epithelia [4-6]. These findings in Drosophila models have led
to the classification of these three genes as tumor suppressor
genes in Drosophila [2].
There are four closely related homologs of Drosophila
melanogaster  dlg  in  mammals  (Dlg1–4),  two  distinct  lgl
homologs  (Lgl1  and  Lgl2),  and  only  one  scrib  in  higher
vertebrates [7-11]. The Dlg, Scrib, and Lgl tumor suppressor
proteins  are  conserved  between  species  in  terms  of  both
sequence and function. Indeed, the mammalian homologs of
these proteins can rescue their respective Drosophila mutants.
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2390Thus, the genetic pathways involved and their roles in the
regulation of cell polarity and mammalian cell proliferation
seem to be evolutionarily conserved [12-14]. Dlg1 and Scrib
are  mouse  orthologs  of  discs  large  and  Scrib  in  the
Drosophila, respectively. Two Lgl homologs, Lgl1 and Lgl2,
have been described in the mouse. Lgl1 is ubiquitous whereas
Lgl2  has  a  tissue-specific  distribution.  Therefore,  Lgl1  is
considered to be the mouse ortholog of Drosophila lgl [15].
Dlg and Scrib are both PDZ (PSD-95/Dlg/ZO-1) proteins.
PDZ proteins contain a common PDZ domain that is a protein
recognition  domain  of  approximately  80–90  amino  acids
[16].  Dlg  belongs  to  the  MAGUK  (membrane-associated
guanylate kinase) protein family. It is composed of several
domains including three PDZ domains, a SH3 (Src homlogy
domain  3)  domain,  a  protein  4.1  binding  motif,  and  a
guanylate kinase (GUK) domain [17].
Scribble is a membrane-associated scaffolding protein
belonging to the LAP (leucine-rich repeats and PDZ domain)
protein family. It contains 16 LRRs (leucine-rich repeats) and
four PDZ domains. In situ hybridization experiments on fetal
mice have revealed that the mouse ortholog of Drosophila
scrib,  Scrb1,  is  expressed  in  several  tissues  including  the
thymus, testis, kidney, esophagus, stomach, and eye [18].
Lgl  proteins  contain  several  conserved  functional
domains including homo-oligomerization domains, a cluster
of phosphorylation sites, and four WD42 repeats [19]. Lgl is
localized at the basolateral membrane domain of Drosophila
epithelial cells [2,20]. However, it is not yet known whether
mammnalian Lgl interacts directly with either Scrib or Dlg.
Although the functions of these proteins seem to be conserved
in mammalian polarized cells (epithelial cells and neurons), it
has been suggested that these proteins function cooperatively
during the establishment of basolateral membrane identity and
during apico-basal polarization.
Several lines of evidence demonstrate that the human
proteins,  hDlg,  hScrib,  and  hLg1,  play  a  role  in  human
epithelial cancers and that decreased expression of the genes
encoding these proteins is correlated with tumor progression
[21-24]. To the best of our knowledge, although the roles of
these  three  proteins  have  been  thoroughly  investigated  in
several  cancers,  a  potential  link  among  the  possible
dysregulation  of  these  genes’  expressions,  their
corresponding  protein  distributions,  and  levels  with  the
emergence, and the progression of ocular tumors has not been
established. A transgenic mouse model has been produced,
leading to the development of retinal pigmented epithelium
(RPE) adenocarcinomas [25]. This model was generated by
inserting a 1.4 kb fragment of Trp1 (tyrosinase-related protein
1) promoter fused to the large T antigen of SV40, which is a
transforming  sequence,  into  the  Y  chromosome.  All
transgenic  mice  were  thus  male.  The  Trp1  enzyme  is
expressed  in  melanocytes/melanoblasts  and  the  retinal
pigmented epithelium (RPE) during development. Expression
of the large T SV40 antigen was first detected at embryonic
stage (E) 10.5, and the first RPE abnormalities were observed
at E15.5. Several preneoplasic foci are observed at this stage
in the RPE. Proliferation of tumor cells occurs in the optic
nerve region and near the anterior chamber where they expand
into a large mass of neoplasic tissue. The tumor consists of
epithelioid  cells  arranged  in  a  tubular  fashion  resembling
human  RPE  adenocarcinomas.  At  one  month  of  age,
transgenic mice exhibit visible enlargement of the eye, leading
to the complete degeneration of the eye after two months of
age. Tumor cells invade the optic nerve, and the mice die at
three months of age. Metastatic invasion of the brain and
lymph nodes are seen in all mice, and the invasion of the
spleen occurs in about 30% of these mice [25]. The Trp1/Tag
mouse model appears to be a very convenient model to study
the involvement of Dlg1, Scrib, and Lgl1 proteins in ocular
carcinogenesis including tumoral invasion.
Here, we investigated the deregulation of their mRNA
and  their  corresponding  protein  levels  as  well  as  their
localization in tumor-affected eyes by reverse transcription
polymerase chain reaction (RT–PCR), western blot analysis,
and  immunohistochemistry.  We  tried  to  establish  the
contribution of each protein to tumor progression in the Trp1/
Tag mouse model. We found that the three proteins were
mislocalized in retinal layers during ocular carcinogenesis,
which could be correlated to the early dysplastic stages of
ocular tumorigenesis whereas levels of mRNA and protein
levels for these proteins were reduced in tumoral eyes but only
at  later  stages.  Our  study  is  the  first  to  demonstrate  the
involvement of Dlg1, Scrib, and Lgl1 proteins in a mouse of
ocular adenocarcinoma and the simultaneous involvement of
these proteins in a same cancer.
METHODS
Animals and tissues: All animals were handled in compliance
with  the  Association  for  Research  in  Vision  and
Ophthalmology  (ARVO)  statement  for  use  of  animals  in
ophthalmic and vision research. CB6 and Trp1/Tag mice were
kept at 21 °C with a 12 h light/dark cycle and fed ad libitum.
We studied control CB6 mice and transgenic TRP1/Tag mice
between the ages of postnatal stage (P) 15 and three months.
RNA extraction and reverse transcription polymerase chain
reaction: We collected one eye from five different mice each
from the control and Trp1/Tag groups for each stage studied
(P15,  P20,  P25,  P30,  and  P90)  and  analyzed  them
independantly. Total RNA were extracted from these eyes
using  the  TRIzol  reagent  (Invitrogen,  Cergy-Pontoise,
France) according to the manufacturer's recommendations.
Five different samples were obtained for each control and
Trp1/Tag group and for each stage. Total RNA (1 μg) was
reverse-transcribed using an oligodT primer with SuperScript
II RNase H reverse transcriptase (Invitrogen-Gibco) in a total
reaction volume of 20 μl. cDNA products were amplified by
PCR in a reaction volume of 10 μl containing 1 μM of each
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2391primer, 0.5 U Taq DNA polymerase (Invitrogen-Gibco), 10X
PCR buffer, 1.5 mM MgCl2, and 0.25 mM dNTP (Promega,
Charbonniéres-les-Bains, France).
Murine Dlg1 specific primers (forward 5′-GAG CAT
TGC ATC TGT TGG-3′ and reverse 5′-AGT GCA GCT GCT
GCT TGTT −3′) were chosen to amplify a 1,557 bp fragment.
Murine Lgl1 was also amplified using the primers 5′-CAT
CGC TTC CTG TGT CTT CA-3′ and 5′-AGG TTC CGC
AGT  TCT  TCT  CA-3′  to  amplify  a  500  bp  fragment.  In
addition, Scrib primers (forward 5′-TGT CAG TGT CAT
CCA GTT CG −3′ and reverse 5′-CCT CGT CAT CTC CTT
TGT AG −3′) were designed so as to amplify an 897 bp
fragment.
Murine E-cadherin (forward 5′-TAC TGC TGA GCT
AAC CCA TG −3′ and reverse 5′-TTC ATC AGG ATT GGC
AGG AC −3′) and N-cadherin (forward 5′-ACG GTG TAT
GCT GTG AGA AG −3′ and reverse 5′-AGG CTT TGA TCC
CTC TGG AA −3′) primers were also chosen to amplify
specific 541 and 591 bp fragments, respectively.
Cyclophilin A and GAPDH were amplified as internal
controls for comparative purposes. The cyclophilin primers
(forward 5′-TGG TCA ACC CCA CCG TGT TCT TCG-3′
and reverse 5′-TCC AGC ATT TGC CAT GGA CAA GA-3′)
were chosen to amplify a 311 bp fragment (Invitrogen-Gibco).
GAPDH primers (forward 5′-GTT GCC ATC AAC GAC
CCC TTC AT −3′ and reverse 5′-ATC CAC AGT CTT CTG
GGT GGC A −3′) were also chosen. PCR products were
analyzed by electrophoresis in 1% agarose gels and visualized
by ethidium bromide staining under ultraviolet (UV) light.
Experiments were performed in triplicate for each eye.
Band intensities were quantified with Image J software. The
relative amount of mRNA was calculated for each eye as the
ratio of the intensity of the each band to the cyclophilin band.
The triplicates were then averaged.
At each stage, the mean of the five measurements of the
control group was used as the reference, and individual ratios
in the control and Trp1/Tag groups were relatively expressed
to this value.
Statistical analysis: All results are expressed as the mean
±standard deviation (SD). The results were compared using
analysis of variance (ANOVA) and Student’s t-test. A value
of  p<0.001  was  considered  statistically  significant.  All
calculations  were  performed  using  the  GraphPad  Prism
software (GraphPad Prism software Inc., San Diego, CA).
Western blot analysis: Total protein was extracted from the
eyes of adult CB6 and Trp1/Tag mice at P15, P20, P25, P30,
and three months of age using extraction reagent (TRIzol;
Invitrogen-Gibco)  according  to  the  manufacturer's
instructions. Protein concentrations were determined with the
Bradford protein assay. Protein (100 µg) from each sample
was mixed with equal volumes of loading buffer (pH 6.8,
60 mM Tris, 10% glycerol, 2% sodium dodecyl sulfate, 5%
2-betamercaptoethanol, 0.01% bromophenol blue), boiled for
5  min,  and  then  separated  by  electrophoresis  in  a  7%
polyacrylamide gel containing SDS. Proteins were transferred
onto a nitrocellulose membrane (Transblot Transfer Medium;
Bio-Rad, Hercules, CA), which was blocked for non-specific
binding  by  incubation  with  5%  skimmed  milk  for  1  h.
Membranes were then incubated for 2 h with rabbit anti-
SAP97 antibody (1:100; sc26532; Santa Cruz, Santa Cruz,
CA), a goat anti-scribble antibody (1:100; sc11049; Santa
Cruz), a rabbit anti-Lgl1 antibody (1/100; provided by Shigeo
Ohno, Department of Molecular Biology, Yokohama, Japan),
and a goat anti-β-actin antibody (C11; 1:1000; Santa Cruz).
Membranes  were  washed  in  PBS-0.5%  Tween-20  and
incubated for 2 h with the appropriate horseradish peroxidase
secondary antibody; anti-rabbit (sc2030, 1:5,000; Santa Cruz)
or  anti-goat  secondary  antibody  (sc2033,  1:5,000;  Santa
Cruz). Proteins were then detected by chemiluminescence
assay (ECL; PerkinElmer Life and Analytical Sciences, Inc.,
Courtaboeuf, France).
Tissue preparation: Control CB6 and Trp1/Tag mice were
killed by CO2 asphyxiation. Eyes were rapidly enucleated and
fixed by incubation for at least 36 h in 4% paraformaldehyde
(PFA) at 4 °C. They were embedded in paraffin and cut with
a microtome (HM355; Microm, Les Ulis, France) into 5 μm
sections, which were mounted on glass slides (Superfrostplus;
Fisher Scientific, Illkirch, France), dried overnight at 37 °C,
and stored at room temperature until use.
Immunohistofluorescence:  Tissue  sections  were
deparaffinized in xylene and rehydrated through a graded
series of ethanol. Sections were then incubated in a blocking
solution overnight at 4 °C with a rabbit anti-Dlg1 (1:100;
provided by J. Hell, University of Iowa, Iowa City, IA), a goat
anti-Scrib (sc-11049, 1:100; Santa Cruz), or a rabbit anti-Lgl1
antibody (1;100, provided by Shigeo Ohno, Department of
Molecular  Biology,  Yokohama,  Japan).  Sections  were
washed in 1X PBS and then incubated with the appropriate
secondary  antibody  in  a  dark  chamber  as  follows.  For
detection of SAP97 and Lgl1, sections were incubated for 1 h
with 1:200 dilution of donkey anti-rabbit Alexa Fluor 488
(A21206; Invitrogen-Gibco). For detection of Scrib, sections
were incubated with 1:200 dilution of donkey anti-goat Alexa
Fluor 488 (A11055; Invitrogen-Gibco). Following incubation
with secondary antibodies, sections were washed in the dark
with 1X PBS and mounted in DAKOCytomation fluorescent
mounting  medium  ((Dako,  Glostrup,  Denmark)).  Sections
were stored at 4 °C until viewing. The sections were viewed
under  a  Leica  SP5  confocal  microscope  (Leica,  Rueil-
Malmaison, France).
In  situ  hybridization:  Riboprobes  were  synthesized  from
Dlg1, Lgl1, and Scrib PCR fragments and labeled with a
digoxygenin (DIG) RNA labeling kit 10X (Promega). In situ
hybridization was performed on deparaffinized, rehydrated
eye sections (5 µm) from control CB6 and Trp1/Tag animals.
Sections were incubated overnight at 65 °C with the probes
Molecular Vision 2008; 14:2390-2403 <http://www.molvis.org/molvis/v14/a276> © 2008 Molecular Vision
2392and  washed  with  1X  Stringent  Wash  Concentrate  (Dako)
according to the manufacturer’s instructions. Sections were
then incubated for 1 h at room temperature with a conjugate
anti-DIG–AP (alkaline phosphatase) antibody and rinsed in
PBS.  Tissue  sections  were  then  incubated  with  the  AP
substrate,  nitro-blue  tetrazolium/5-bromo-4-chloro-3-
indolyl-phosphate (NBT/BCIP), for 30 min in the dark. Slides
were examined under a light microscope. We applied the same
quantity of probe (sense and antisense) to each slide and
treated all slides in a single experiment so that they could be
compared. Experiments were performed in triplicate.
RESULTS
Dlg1 mRNA and protein localizations in mouse retina:
Localization of Dlg1 mRNA and protein in control
mouse retina—We studied the expression of murine Dlg1 in
whole eyes from control CB6 mice using in situ hybridization
on longitudinally oriented adult mouse eye tissue sections.
Dlg1 mRNA was detected in the neuroretina (Figure 1A,B)
but also in non-retinal ocular structures (data not shown). Dlg1
mRNA was present within the neural retina, in the ganglion
cell layer (GCL), the inner nuclear layer (INL), and the outer
nuclear layer (ONL; Figure 1B). Very strong staining was also
detected  in  the  outer  plexiform  layer  (OPL)  and  in  the
photoreceptor inner segments (IS). However, very faint Dlg1
mRNA staining could be detected in the inner plexiform layer
(Figure 1B). We detected Dlg1 mRNA in the retinal pigment
epithelium  (RPE),  choroidal  melanocytes,  and  choroidal
vascular endothelial cells (Ch; Figure 1B). The retinal Dlg1
immunostaining pattern throughout the neural retina mostly
matched with the retinal Dlg1 mRNA distribution detected by
in situ hybridization with the exception of the inner plexiform
layer  (Figure  1D).  Moreover,  Dlg1  labeling  in  the  inner
nuclear layer was more intense at both sides of this layer than
in its center (Figure 1D). The specificity of detection for
mRNA and protein were confirmed by the negative control
(Figure 1A,C).
Dlg1 protein localization in Trp1/Tag mouse eye—We
explored the potential changes in the localization of Dlg1
protein in the retina of transgenic mice compared to the control
mice (Figure 1E-K). At P15, Dlg1 protein distribution in the
retina of transgenic mice was similar to that observed in the
control mice of the same age (Figure 1E). At P20 and P25
(Figure 1F-H), the neuroretina of transgenic mice was highly
disorganized at the posterior pole. This disorganization of the
retina  was  associated  with  retinal  dysplasia  and  the
appearance of a tumor cell mass. Dlg1 labeling in the central
retina remained unchanged compared to control mice whereas
we observed a lower intensity of Dlg1 immunolabeling in the
OPL than in control eyes (Figure 1F). Immunolabeling in the
INL appeared to be more diffuse in the transgenic mice than
in control mice, possibly reflecting a more intense labeling at
cortical regions than at membranous regions. In the peripheral
retina, retinal dysplasia was also associated with reduced Dlg1
labeling in the OPL as described in the central retina (Figure
1G). At these stages, tumor cells invading the neural retina
from the transformed RPE stained positive for Dlg1 (Figure
1H). At P30 and three months of age (Figure 1I-K), this
disorganization was amplified, spreading from the posterior
to  the  anterior  pole.  However,  at  these  stages,  Dlg1
immunolabeling in the retina was less intense than in control
mice  at  the  same  age  (Figure  1I).  In  addition,  Dlg1
immunolabeling  appeared  to  be  more  diffuse  in  the  INL
(Figure 1I). Dlg1 immunolabeling was also reduced in the
retina due to both the loss of photoreceptor outer and inner
segments and the loss of a non negligible number of whole
photoreceptor cells (Figure 1I). In the posterior pole, the RPE
and choroid layers were still positive for Dlg1 as determined
by immunohistochemistry (Figure 1J). The immunostaining
of the tumor cell masses appeared to be less intense at these
stages than at previous ones (Figure 1K). These observations
were all validated in several sets of repeated experiments.
Scrib mRNA and protein localization in mouse retina:
Localization of Scrib mRNA and protein in control
mouse  retina—Scrib  mRNA  distribution  was  also
investigated in adult mouse retina. In the retina, we detected
Scrib mRNA in the ganglion cell layer, the inner nuclear layer,
the outer nuclear layer, and the outer plexiform layer. As
described for Dlg1 expression, very faint staining of Scrib
mRNA could be detected in the inner plexiform layer (Figure
2B).  However,  Scrib  was  very  strongly  expressed  in  the
photoreceptor inner segments (IS). We also detected Scrib
mRNA  in  the  retinal  pigment  epithelium,  choroidal
melanocytes, and choroidal vascular cells (Figure 2B). The
specificity of Scrib mRNA detection was confirmed using the
sense probe, which gave no significant hybridization signal in
ocular  structures  (Figure  2A).  The  retinal  Scrib
immunostaining pattern throughout the neural retina mostly
matched  with  its  mRNA  distribution  detected  by  in  situ
hybridization, with the exception of the inner plexiform layer
(Figure  2D,E).  Additionally,  a  stronger  level  of
immunostaining was found in the OPL and the photoreceptor
inner segments/elm (external limiting membrane) structures
(Figure 2D,E). No Scrib immunolabeling was observed in the
negative control with the exception of the autofluorescent
photoreceptor outer segments (OS; Figure 2C).
Distribution of Scrib protein in the Trp1/Tag mouse
eye—We investigated potential differences in the pattern of
Scrib protein in the retina during the development of the ocular
tumors between Trp1/Tag transgenic mice and normal control
mice at each stage (Figure 2F-P). At P15, the normal neural
retina continued to display significant Scrib immunoreactivity
(Figure 2F). However, intense Scrib immunostaining with a
highly localized distribution pattern was observed in the OPL
of normal adult mice whereas Scrib immunolabeling in the
OPL of P15 transgenic mouse retinas was reduced. Similarly,
Scrib  immunolabeling  in  the  retinal  nuclear  layers  was
restricted to the cell membrane region in control retinas but
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2393Figure 1. Dlg1 mRNA distribution in the control retina and protein localizations in the adult retina and during development from control and
Trp1/Tag mice using immunohistochemistry. A and B show Dlg1 mRNA localization whereas C-K show the Dlg1 protein distribution in the
adult mouse retina from the control mouse (C and D) and from the Trp1/Tag mouse model (E-K) at P15 (E), P20 and P25 (F-H), P30, and
three months (I-K). A and C show the negative controls for B and D, respectively. Dlg1 mRNA and protein distributions were widely expressed
in the ganglion cell layer (GCL), the inner nuclear layer (INL), the outer nuclar layer (ONL), and the photoreceptor inner segments (IS) of
the control mouse retina. Very strong staining was detected in the outer plexiform layer (OPL) and the external limiting membrane (elm).
However, faint staining of Dlg1 mRNA was found in the inner plexiform layer whereas its protein was strongly detected. Futhermore, in the
inner nuclear layer, Dlg1 labeling was stronger at either side of the layer than in its center (indicated by an asterisk; D). Retina from the
transgenic Trp1/Tag mouse model of ocular tumor continued to express Dlg1 protein (E-K). However, changes in the distribution of Dlg1
protein was observed from P20. In the central region adjacent to the mass of tumoral cells, Dlg1 immunolabeling in photoreceptor segments
(IS) seemed to be reduced (F,G,I). A lower intensity of Dlg1 immunolabeling was shown in the OPL compared to the control retina (F,G,I).
We also observed that immunolabeling in the INL appeared to be more diffuse in transgenics than in controls, possibly reflecting more labeling
at the cortical regions than at membranous regions (F,I). In addition, from P30, the RPE and choroid (Ch) no longer stained positive for Dlg1
protein (J) in the posterior pole. The tumor cells (TC) had very faint staining for Dlg1 protein at these stages (H,K).
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2394was more diffuse in transgenic mice (Figure 2F). We found
intense Scrib immunostaining in the abnormally thickened
RPE  cells.  Scrib  immunoreactivity  was  particularly
prominent nearby or within the cytoplasmic cell membrane in
these cells but was also detected in the cytoplasm (Figure 2F).
The same findings were observed for the P20, P25, and P30
retinas (Figure 2G,I,L). At the P20 and P25 stages, the tumor
cells invading the neural retina exhibited significant Scrib
immunostaining,  which  appeared  to  be  localized  to  the
cytoplasmic membranes (Figure 2H,J,K). The pattern of Scrib
immunostaining remained unchanged at P30 in transgenic
mice both in the neural retina and RPE compared to previous
stages in Trp1/Tag mice (Figure 2L). However, at this stage,
the  uveal  tract  appeared  to  display  very  faint  Scrib
immunoreactivity  (Figure  2M).  Tumor  cells  still  had
detectable Scrib immunoreactivity, but a significantly lower
level was observed than that observed at P25 (Figure 2N).
Additionally, a diffuse pattern of Scrib immunoreactivity was
Figure 2. Scrib mRNA distribution in control retina and protein localizations in adult retina and during development from control and Trp1/
Tag mice using immunohistochemistry. A and B show Scrib mRNA localization whereas C-P show Scrib protein distribution in adult mouse
retina from the control mouse (C-E) and the Trp1/Tag mouse model (F-P) at P15 (F), P20 (G,H), P25 (I-K), P30 (L-N), and three months
(O,P). A and C show the negative controls for B and D, respectively. In the retina, the Scrib mRNA and protein were observed in the ganglion
cell layer (GCL), the inner nuclear layer (INL), the outer nuclear layer (ONL), and the outer plexiform layer (OPL). No mRNA expression
was detected in the inner plexiform layer, but its protein was detected (in the IPL). Very strong levels of expression were detected in the
photoreceptor inner segments (IS) and the external limiting membrane (elm). We also detected Scrib in the retinal pigment epithelium (RPE),
choroidal melanocytes, and choroidal vascular cells (Ch). The neural retina continued staining positive for the Scrib protein in ocular tumor
development in Trp1/Tag mice (F-P). However, from P15, strong staining was lost in the OPL (F,G,I,L). Scrib immunolabeling in the nuclear
layers appeared to be more diffuse rather than restricted to cell membranes as observed in the control retina (F,G,I,L). The thickening of the
pigmentary epithelium (RPE) was also positive for Scrib, which was predominantly localized to the cell membrane but also present in the
cytoplasm (F). In addition, low levels of Scrib seemed to be present in the uvea (Ch; M). The intensity of the Scrib protein labeling in tumoral
cells was markedly reduced and no longer restricted to cell membranes as described for P25. Scrib protein was detectable in tumor cells from
P20 (H,K). However, at P30 and three months, no significant Scrib immunolabeling could be detected in tumoral cells (N,P).
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2395observed in these cells. Unlike the preceding stages of tumor
progression, no significant Scrib immunolabeling could be
detected in tumoral cells at three months of age (Figure 2P).
While  the  uveal  tract  displayed  very  faint  Scrib
immunostaining at P30, the tumor cell mass, which had clearly
invaded this structure by this stage, displayed significant Scrib
immunoreactivity (Figure 2O).
Lgl1 mRNA and protein localization in mouse retina:
Lgl1 mRNA and protein in control mouse retina—
Similar to for Dlg1, Lgl1 mRNA was widely distributed in the
adult retina (Figure 3). No Lgl1 staining was observed in
negative control using sense probe (Figure 3A). In the neural
retina, Lgl1 mRNA was found in the ganglion cell layer, the
inner  nuclear  layer,  the  outer  nuclear  layer,  and  the
photoreceptor inner segments (IS). Staining was stronger in
the IS than in any other compartment of the neural retina
(Figure 3B). We did not detect significant staining in the inner
plexiform layer whereas weak mRNA levels were observed
in the outer plexiform layer (Figure 3B). Lgl1 mRNA staining
was also observed in the RPE, the uveal melanocytes, and
choroidal  endothelial  vascular  cells  (Figure  3B).  The
distribution of Lgl1 immunoreactivity throughout the normal
adult mouse retina appeared to be very similar to that of its
RNA  distribution  (Figure  3D).  However,  strong
homogeneous Lgl1 immunostaining was observed in the outer
plexiform layer and the photoreceptor inner segments. The
external  limiting  membrane  was  also  intensely
immunostained  for  Lgl1  (Figure  3D,E).  For  the  negative
control,  immunolabeling  was  only  observed  in  the
autofluorescent photoreceptor outer segments (Figure 3C).
Lgl1 protein localization in Trp1/Tag mouse eye—The
distribution of Lgl protein was also determined in the Trp1/
Tag retina tissue and compared to control one (Figure 3C-E).
At P15, the cellular distribution of Lgl1 in transgenic mice
appeared to be identical to that observed in the P15 normal
control  retinas  (Figure  3F).  However,  in  the  thickening
observed in the RPE, the staining seemed to be more closely
linked to the cytoplasmic region than to the membrane of RPE
cells (Figure 3F). The choroid had reduced levels of Lgl1
immunostaining  at  this  stage.  From  P15,  Lgl1
immunolabeling  appeared  to  be  more  diffuse  in  the  INL,
possibly due to its presence both in the intracytoplasmic and
membrane  regions  (Figure  3F,G,I,K).  Additionally,  Lgl1
immunolabeling of the INL and OPL appeared be less intense
than in the control retinal tissue sections from P25 (Figure
3I,K).
Tumor  cells  had  detectable  Lgl1  immunoreactivity  at
P20, P25, P30, and three months of age (Figure 3J,L,N).
However, at the P30 stage, the immunostaining of these tumor
cell masses appeared to be less intense than at the others stages
(Figure 3L).
Downregulation of Dlg1, Lgl1, and Scrib expression during
tumor  development  in  Trp1/Tag  transgenic  mice:  Our
findings from immunohistochemistry experiments suggested
a decrease of Dlg1, Lgl1, and Scrib protein levels during the
development of the ocular adenocarcinoma of the Trp1/Tag
mouse model. Therefore, we determined the levels of the
corresponding mRNAs in these mice using semi-quantitative
methods. We used semi-quantitative RT–PCR to compare the
amount of each mRNA in total RNA extracts from normal
(CB6)  eyes  and  tumor-derived  eye  tissue  from  Trp1/Tag
transgenic mice at different stages (Figure 4). The levels of
Dlg1, Lgl1, and Scrib mRNAs were analyzed at P15, P20,
P25, P30, and three months of age. Cyclophilin was used as
an internal standard for quantifying changes in levels for each
class of mRNA (Figure 4). The relative amount of each mRNA
was calculated as the ratio of the intensity of the each band to
the cyclophilin band.
The PCR amplified product obtained using the Dlg1-
specific primers produced a clear band of the predicted size,
1,557 bp. Dlg1 mRNA was present at all postnatal stages
studied in eyes from control and Trp1/Tag mice. We did not
observe any changes in Dlg1 expression at P15, P20 (data not
shown),  or  P25  following  normalization  with  respect  to
cyclophilin expression in Trp1/Tag mice compared to control
ones at the same stages. However, Dlg1 expression levels
were four times lower in the Trp1/Tag model than in wild-type
mice at P30 (Figure 4B). This reduction in Dlg1 transcript
levels was not observed at the age of three months in Trp1/
Tag mice compared to the control mice (Figure 4A,B). The
PCR-amplified product obtained using Scrib-specific primers
produced  a  clear  band  of  the  predicted  size,  897  bp.  As
described above for Dlg1, Scrib mRNA was present at all
postnatal stages studied in control and Trp1/Tag mice (Figure
4C). The Scrib/cyclophilin mRNA ratio in whole eyes showed
significantly lower levels of Scrib gene transcription in tumor-
derived eye tissue from Trp1/Tag mice at P30 (2.3 times
lower) than in normal control eyes at the same stage (Figure
4D). Notably, this decrease in Scrib gene expression was
observed at the same stage of tumor development as that
corresponding to the decrease observed in Dlg1 mRNA levels.
While the decrease in Dlg1 transcription levels was only seen
at the P30 stage, Scrib transcription levels were also decreased
(1.9 fold) at the final three month stage compared to the
control  mice  (Figure  4D).  Similarly  to  Dlg1  and  Scrib
expression, Lgl1 mRNA was expressed at all postnatal stages
studied  in  control  and  Trp1/Tag  mice  (Figure  4E).  Lgl1
transcripts levels in ocular total RNA samples extracted from
Trp1/Tag  model  at  P30  were  significantly  lower  than  in
control  samples  at  this  stage.  However,  no  significant
decrease in Lgl1 mRNA levels could be detected at the age of
three  months,  unlike  that  observed  for  Scrib  mRNA
expression (Figure 4F). The same results were obtained using
GAPDH as an additional internal control used for comparative
purposes (data not shown).
Differential decreases in Dlg1, Scrib, and Lgl1 protein levels
during cancer progression in Trp1/Tag mice: To confirm our
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2396observations, we used western blot to determine protein levels
(Figure 4G). Protein levels were analyzed in protein extracts
from whole eyes of control and Trp1/Tag mice at the same
stages (P15, P20, P25, P30, and three months) using the same
antibodies used in immunohistochemistry experiments. No
changes in protein levels were observed between P15 and P25
Figure 3. Lgl1 mRNA distribution in control retina and protein localizations in adult retina and during development from control and Trp1/
Tag mice using immunohistochemistry. A and B show Lgl1 mRNA localization whereas C-N show Lgl1 protein distribution in the adult
mouse retina from the control mouse (C-E) and Trp1/Tag mouse model (F-N) at P15 (F), P20 (G,H), P25 (I,J), P30 (K,L) and three months
(M,N). A and C show the negative controls for B and D, respectively. In the retina, Lgl1 mRNA and protein were found in the ganglion cell
layer (GCL), the inner nuclear layer (INL), the outer nuclear layer (ONL), the photoreceptor inner segments (IS), the external limiting
membrane (elm), the RPE, and the melanocytes and vascular cells in the choroid (Ch; B). No mRNA staining was found in the inner plexiform
layer (IPL) or in the outer plexiform layer (OPL; B), but a weak trace of protein was observed (D). Lgl1 labeling in the retinal nuclear layers
seemed to be exclusively membranous (D,E). Lgl1 protein distribution in the retinas from the Trp1/Tag mouse model changed during tumoral
development. In the INL and the RPE, Lgl1 immunolabeling appeared to be both membranous and cytoplasmic compared to the control retina
(F,G,I,K). Lgl1 protein also appeared to be reduced in the INL, the OPL, and the elm from P25 (I,K). The tumor cells (TC) also displayed
staining for Lgl1 protein during tumoral development in Trp1/Tag mice (H,J,L,N). However, very weak Lgl1 staining was detected in tumor
cells at P30 (L).
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2397Figure 4. Dlg1, Scrib, and Lgl1 mRNA and protein expressions in mouse whole eyes during tumor development and in control eyes. Semi-
quantitative RT–PCR was used to determine the relative amounts of Dlg1 (A), Scrib (C), and Lgl1 (E) mRNA in mouse whole eye tissue at
P25, P30, and three months in CB6 control and Trp1/Tag mice. Cyclophilin was used as an internal control. Relative levels were calculated
as the ratio of the intensity of each PCR band to the cyclophilin band. B, D, and F shows means of the ratio of expression corresponding to
A, C, and E, respectively. G shows corresponding western blot analysis. The blot was counterstained with anti-β-actin antibody as a loading
control. Specific bands corresponding to Dlg1 (140 kDa), Scrib (210 kDa), Lgl1 (112 kDa), and β-actin (42 kDa) were detected in all extracts.
H shows the relative levels of each protein, which were quantified and normalized using β-actin as the internal standard. I shows E-cadherin
and N-cadherin expressions using RT–PCR in control and TRP1/Tag mice. Error bars indicate SEM. Asterisks indicate statistically significant
results (p<0.001). Dlg1, Scrib, and Lgl1 protein levels were reduced in the whole eye from the adenocarcinoma model at P30 whereas only
Dlg1 and Scrib protein were reduced at three months (G,H). E-cadherin expression in total RNA samples extracted from whole eyes was
much lower in the Trp1/Tag model than in the control mice at the P30 and three month stages (H). An upregulation of N-cadherin expression
was associated with E-cadherin downregulation at these stages (I).
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2398in Trp1/Tag mice compared to the control mice (data not
shown). Consistent with the reduced mRNA levels at P30,
only a low level of Dlg1 was detected in Trp1/Tag mice
compared to the control mice at P30. However, whereas Dlg1
mRNA was not reduced at three months of age in the ocular
tumor total RNA samples, we found that the protein levels
were still low at this stage compared to the control mice
(Figure 4H). Similarly, Scrib protein levels were decreased at
both the P30 and three month stages of tumor development in
Trp1/Tag mice compared to control mice. Additionally, our
data obtained for Lgl1 mRNA expression were supported by
western blot analysis. We found decreased Lgl1 protein levels
in proteins extracts from tumor-derived tissue when compared
to proteins samples from control mice at P30 only (Figure 4H).
In summary, both RT–PCR and western blotting revealed
a downregulation of Dlg1, Scrib, and Lgl1 in whole eyes from
Trp1/Tag  transgenic  mice  with  an  inverse  correlation
observed reproducibly between protein levels and the tumor
invasion stage in our ocular tumor model.
Downregulation of E-cadherin mRNA transcription: It has
been long established that cancer development is associated
with a loss of cell adhesion. In particular, a switch from E-
cadherin to N-cadherin interactions contributes to a stroma-
oriented cellular adhesion profile with increased tumor cell
motility and invasive properties. Some studies suggest that
Scrib and Lgl proteins can regulate E-cadherin expression in
Drosophila [26,27]. We decided to analyze E-cadherin and
N-cadherin expression by RT–PCR using specific primers.
RT–PCR analysis showed that E-cadherin expression in total
RNA samples extracted from whole eyes was much lower in
the Trp1/Tag model than in control mice at the P30 and three
month stages (Figure 4I). We also observed an upregulation of
N-cadherin expression, which is associated with E-cadherin
downregulation, at these stages (Figure 4I).
DISCUSSION
There is growing evidence to suggest that Dlg, Scrib, and Lgl
proteins are important mediators controlling cell polarity and
potential tumor suppressors in mammalian cells as described
for their Drosophila homologs. A transgenic mouse model
was previously developed in which the SV40 T antigen is
produced under the control of the Trp1 promoter [25]. This
model  is  characterized  by  tumor  formation  in  the  retinal
pigment epithelium (RPE). The mice develop primary ocular
tumors, which start to develop from the RPE before birth and
progressively invade the optic nerve and metastasize in the
brain,  lymph  nodes,  and  spleen.  The  Trp1/Tag  model  is
relevant in carcinogenesis, mimicking the development of the
equivalent human cancer (adenocarcinomas), and allowing
the study of the dissemination process. The aim of our study
was  to  investigate  the  gene  expressions  and  protein
distribution and levels for mouse Dlg1, Scrib, and Lgl1 during
mouse tumorigenesis in this transgenic model of ocular cancer
and to establish their potential involvement in the malignancy
process. Specifically, we determined whether Dlg1, Scrib, or
Lgl1  levels  and  distributions  were  altered  during  tumor
progression.
We first found that Dlg1, Scrib, and Lgl1 are widely
distributed in adult mouse retina. More specifically, these
three  proteins  were  detected  in  mouse  retinal  neurons.
Furthermore, strong staining for Dlg1 and Scrib was observed
in the same layers of the retina, the OPL, and photoreceptors
inner segments (IS) from postnatal developmental stages to
adulthood. These results complement those of Nguyen et al.
[28] who found that Dlg1 and Scrib were colocalized in certain
regions of the mouse retina. These findings suggest that Dlg1
and Scrib proteins act cooperatively. Importantly, we also
detected strong staining for the Lgl1 protein in these same
retinal layers. Our results seem to confirm that these three
proteins may act altogether cooperatively in the same retinal
layers. We demonstrated that each of the three proteins studied
has  a  distinct  distribution  in  the  neural  retina.  Dlg1  was
particularly abundant in the INL and OPL, and Scrib protein
was predominant in the GCL and INL whereas staining for
Lgl1 was strongest in the ONL. These different localization
patterns  suggest  that  these  three  proteins  as  well  as
cooperative  functions  in  the  regions  where  they  are
colocalized  might  also  display  distinct  functions.  These
results  also  suggest  that  each  of  these  proteins  might  be
associated with distinct, specific subpopulations of neurons in
the  adult  mouse  retina.  Further  experiments  using  double
immunolabeling  experiments  may  help  to  confirm  these
hypotheses.  Data  collected  from  both  Drosophila  and
mammals suggest that the role of the Dlg protein in clustering
and trafficking receptors involved in neurotransmission have
been  strongly  conserved  in  evolution  [29,30].  Our
observations in normal adult mouse retinas support the notion
that Dlg1 may share the same functions of clustering and
trafficking  of  synaptic  proteins  and  may  be  required  for
normal retinal function. This is supported by previous studies
showing  that  Dlg1  is  essential  for  retinal  response  in
Drosophila [31]. Mouse Scrib in retinal neurons may also
retain some of the properties that they display in Drosophila
in synaptic organization and plasticity [32]. Previous reports
suggest that the Lgl protein may also have important functions
in the retina related to its regulation of exocytosis through its
interaction  with  target  soluble  N-ethylmalemide–sensitive
factor attachment protein receptor (t-SNARE), a function that
seems to be conserved between different species and cell types
[33-35].  Indeed,  mouse  Lgl1  may  act  to  restrict  protein
localization at particular membrane sites by regulating a major
exocytosis pathway in retinal neurons. However, additional
experiments will be required to determine whether all the
potential functions of these proteins are related to synaptic
functions.
We also examined these proteins in the ocular tissues of
Trp1/Tag mice. We showed that immunoreactive staining for
Dlg1, Lgl1, and Scrib in the retinal outer plexiform layer was
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2399lower in these mice than in controls. We also found reduced
levels of Scrib and Lgl1 in the external limiting membrane.
Consistent with these observations, we found reduced levels
of the Dlg1, Scrib, and Lgl1 proteins in western blots at the
P30 stage in Trp1/Tag mice. At this stage, tumor cells invade
the optic nerve. Our results indicate that there is a correlation
between decreased levels of these proteins and the invasion
of  adjacent  tissues.  These  proteins  display  several  crucial
properties  likely  to  be  involved  in  major  retinal  neuronal
functions  such  as  synaptic  formation,  functioning,  and
plasticity. Thus, the effects of their downregulation should be
assessed through examination of synaptic and spine structure
morphology  using  specific  immunohistochemical  markers
and combined with functional exploration of retinal functions
based on electrophysiological analyses of Trp1/Tag mice.
Whereas the downregulation of Dlg1 and Lgl1 observed
at P30 was no longer obvious at later stages in the progression
of mouse ocular adenocarcinoma, the downregulation of Scrib
mRNA  and  protein  persisted.  Consistent  with  our  results
obtained by semi-quantitative RT–PCR and western blots of
total RNA and protein from whole eyes of transgenic mice,
we observed a greater reduction in the intensity of the Scrib
specific immunostaining in ocular tumor-derived tissue than
for Dlg1 or Lgl1 in the same ocular tissue. The reasons for the
differences observed in the regulation of these proteins remain
unclear. Previous studies suggest that the roles of Lgl1 in
controlling cell proliferation and apico-basal polarity in the
developing eye of Drosophila are separable [36]. Indeed, the
results exposed suggest that high levels of Lg1l are required
to reduce proliferation whereas lower Lgl1 levels are needed
for  the  maintenance  of  apico-basal  cell  polarity.  Previous
studies on Dlg1 mutants have also suggested that a specific
threshold  level  of  protein  is  required  for  cell  polarity
regulation whereas a higher level of protein is required for the
control of cell proliferation [37,38]. However, the analysis of
Scrib did not suggest that the two functions were independent.
However,  it  should  be  noticed  that  the  deletion  of  PDZ
domains leads to only mild polarity defects and to moderate
overproliferation  [39].  The  hypothesis  proposed  for
explaining these facts is that Scrib acts primarily to regulate
apico-basal polarity and that loss of polarity itself disrupts
proliferation control. Thus, these two distinct processes seem
to  be  coordinated  and  cannot  be  separated  in  Drosophila
[39].  Further  experiments  will  be  required  to  determine
whether this is the case in mammals.
In  addition  to  the  reduced  protein  levels  observed  in
western  blots,  we  showed  that  immunostaining  for  Dlg1,
Scrib, and Lgl1 in the inner nuclear layer was more diffuse for
Trp1/Tag retinas during tumor development than for wild-
type mouse retinas. We also showed diffuse staining for Scrib
in the outer nuclear layer. Dlg1, Lgl1, and Scrib proteins
detected in the immunolabeled cells of the ONL and INL of
control mouse retinas seemed to be normally localized close
to the cytoplasmic membranes. Staining appeared to be more
predominant in intracellular cytoplasmic regions in the ocular
tumor mouse model. This abnormal mislocalization of Dlg1,
Lgl1, and Scrib was also found in epithelial cells, the corneal
epithelium, lens epithelium, and the RPE of the transgenic
mouse model (data not shown). Only Dlg1 and Scrib proteins
displayed an increased cytoplasmic distribution in tumor cells.
Several  previous  studies  have  reported  that  Lgl1  protein
follows  this  pattern  of  translocation  in  human  malignant
melanoma [27]. A similar process of translocation of the Dlg1
protein occurs in cervical intraepithelial neoplasia [23,40].
Additionally,  the  Scrib  protein  also  changes  its  cellular
location during the progression of colon cancer [21]. Our
results support the importance of intracellular mislocalization
of  Dlg1,  Scrib,  and  Lgl1  during  cancer  development  as
suggested previously [41,42]. The mechanism(s) contributing
to these changes remain(s) to be determined. However, the
potential involvement of atypical Protein Kinase C (aPKC) in
a  mechanism  underlying  Lgl1  mislocalization  could  be
explored in our model. Under normal conditions, aPKC is
localized at the apical domain and is able to phosphorylate
Lgl1. This Lgl1 phosphorylation induces its detachment from
the plasma membrane due to a conformational change. The
displacement of phosphorylated Lgl1 results in the inhibition
of  Lgl1  function  at  the  apical  cellular  domain  and
subsequently the inhibition of aPKC function by Lgl1 at the
basolateral domain [43,44]. This regulation by aPKC was
observed in epithelial cells [45] and mouse brain fibroblasts
[46]. Additionally [42], showed that the presence of aPKC in
the cortex leads to the cytoplasmic release of Lgl1 and massive
overgrowth  in  Drosophila  melanogaster.  In  ovarian
carcinomas, the aPKC ξ isoform displays an apical cortical
distribution and Hugl1 is released from the membrane into the
cytoplasm, reminiscent of events observed in the Drosophila
model  [42].  It  appears  likely  that  this  mechanism  also
regulates Lgl1 intracellular localization in the mouse retina.
This hypothesis could be tested in experiments determining
whether the Lgl1 mislocalization observed in the tumor cells
of our transgenic mouse model is linked to abnormal aPKC
cellular  localization.  Similarly,  given  that  the  Dlg1/GUK
complex is required for proper synaptic localization of Scrib in
Drosophila [47], it follows that Dlg1 mislocalization could
trigger  the  concomitant  mislocalization  of  Scrib.  Future
studies investigating this hypothesis would be of interest. The
mechanism underlying Dlg1 mislocalization remains to be
determined. In summary, we showed that in a mouse model
of ocular adenocarcinoma, Dlg1, Scrib, and Lgl1 are present
in  the  retina  and  tumor  cells,  albeit  displaying  different
patterns  of  intracellular  distribution  in  comparisons  with
normal mouse eyes of the same age. These alterations are
found in the neural retina and RPE tumor cells as early as at
the P15 stage of tumor progression.
We  also  found  a  reduction  in  Dlg1,  Scrib,  and  Lgl1
mRNA and protein levels at the later P30 stage. Consistent
with our results, the altered localization of Dlg1, Lgl1, and
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their  downregulation  could  be  considered  as  a  late  stage
marker in the progression of ocular tumor development. The
downregulation  of  these  proteins  and/or  changes  in  their
intracellular localization may contribute to the transformation
and development of ocular tumors in our mouse model. The
mislocalization and downregulation of Dlg1, Scrib, and Lgl1
in our model may alter their normal functions in controlling
cell  proliferation  and  cell  migration.  Further  studies  are
needed to clearly elucidate the molecular and biochemical
mechanisms responsible for the different expression patterns
and downregulation observed in the RPE adenocarcinoma of
our mouse model.
The  downregulation  of  Dlg1,  Lgl1  and  Scrib  gene
expression observed in Trp1/Tag mice was only detected at
P30, a stage corresponding to the beginning of the invasion
process. Our results suggest an involvement of these proteins
in the dissemination and occurrence of metastases. This could
be  confirmed  by  studying  the  phenotypes  of  Drosophila
mutants. Loss of Scribble, Dlg or Lgl leads to the tumorous
overgrowth of epithelial tissues in Drosophila imaginal discs.
The  transplantation  of  these  mutated  tissues  into  new
Drosophila hosts appears to be sufficient to confer migratory
properties  to  the  transplanted  mutated  epithelial  cells  and
result in tumor formation at distant sites in the host [48].
Furthermore, some studies have demonstrated the role of Dlg,
Lgl and Scrib in the control of cell migration in Drosophila,
zebrafish,  and  mammals  [46,49-52].  Consistent  with  the
potential role of these proteins in the migration of tumor cells
in our ocular tumor model, we also showed that E-cadherin
mRNA is reduced at the P30 and three month stages in our
ocular tumoral mouse model. This suggests that Scrib and
Lgl1  mouse  homologs  may  regulate  cell  migration  by
alterating E-cadherin gene expression. This is consistent with
previous  findings.  In  Drosophila  melanogaster,  a  Scrib
mutation  in  Ras-transformed  eye  disc  cells  suppresses  E-
cadherin  expression,  inducing  invasion  of  the  basement
membrane and metastasis [26]. However, the role of Scrib in
controlling E-cadherin expression remains unclear. Indeed,
unlike in Drosophila melanogaster, the reduction of Scrib
levels in MDCK cells had no effect on E-cadherin expression
[52]. In human melanoma, a loss of Hugl1 is associated with
E-cadherin downregulation [27]. Although the possibility of
E-cadherin regulation by Scrib or Lgl remains undetermined,
our results are consistent with a previous study in transgenic
mice that strongly suggests that the loss of E-cadherin directly
promotes the transition of benign adenoma into carcinoma
[53].  We  also  found  that  the  loss  of  E-cadherin  gene
expression  was  correlated  with  the  upregulation  of  N-
cadherin gene expression in our mouse model. Interestingly,
the switch from E-cadherin to N-cadherin is a marker of the
epithelial to mesenchymal transition (EMT). This abnormal
switch leads to the loss of intercellular junctions, provoking
the detachment of tumor epithelial clusters. This property is
typically displayed by metastasizing cells and is a feature of
aggressive tumors [54]. These findings also suggest that Dlg1,
Scrib, and Lgl contribute to EMT in our ocular tumor mouse
model, a process relevant to human cancers [27]. However,
this hypothesis should be confirmed by additional appropriate
experiments.
To conclude, this is the first study demonstrating the
simultaneous deregulation of expression of the three major
suppressor  genes  conserved  between  Drosophila  and
mammals. We also demonstrated changes in the behavior of
these proteins during ocular carcinogenesis including their
mislocalization and downregulation. Both the mislocalization
and downregulation of Dlg1, Scrib, and Lgl1 proteins seemed
to be correlated to tumor progression, which was determined
by the acquisition of new properties in cancer cells, in our
mouse model of adenocarcinoma. Our results suggest that
alterations of Dlg1, Scrib, and Lgl1 functions could promote
tumorigenesis  by  first  promoting  hyperplasia  and  second
resulting  in  a  loss  of  cell  polarity,  thereby  reducing  cell
adhesion and facilitating aggressive overgrowth and invasive
behavior. Studies of biopsies and samples from human ocular
adenocarcinomas are now required to confirm the relevance
of  our  findings.  Nevertheless,  our  findings  together  with
previous studies provide increasing evidence that Dlg, Scrib,
and Lgl Drosophila homologs are involved in pathways that
play a major role in cancer development.
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